Advanced Non-Melanoma Skin Cancer in Veterans: Incorporating Advances in Immune Checkpoint Inhibitors to Optimize Outcomes

This program will explore key clinical practice insights for patients with advanced Non-Melanoma Skin Cancer

Event

Louis Stokes Cleveland VA

Overview

In this program we discuss evidence-based care for advanced NMSC management. “Advanced Non-Melanoma Skin Cancer in Veterans: Incorporating Advances in Immune Checkpoint Inhibitors to Optimize Outcomes” was developed and produced by Plexus Communications, the Association of VA Hematology/Oncology, and Medical Education Resources, and supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

This site represents our opinions only. See our full Disclaimer and Terms of Use Agreement